arrow
K

Kyle Hebert

Dana-Farber Cancer Institute
H指数:13
被引数:1,164

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Expression of HLA-B*35 is Associated with an Increased Risk of CMV Viremia and Clinically Significant CMV Infection following PTCy-based Hematopoietic Cell Transplantation

HLA-B*35的表达与PTCy-based造血细胞移植后巨细胞病毒(CMV)病毒血症及临床显著CMV感染风险的增加相关。

2025-09-210
PRE
The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated Toxicities
2025-02-010
PRE
Expression of HLA-B*35 Is Associated with an Increased Risk of CMV Viremia and Clinically Significant CMV Infection in Patients Receiving Ptcy-Based Hematopoietic Cell Transplantation

HLA-B*35的表达与接受Ptcy为基础造血细胞移植的患者发生巨细胞病毒(CMV)病毒血症和临床显著CMV感染风险增加相关。

BLOOD
IF23.1
2024-11-050
PRE
Early CMV Viral Load Burden Predicts Late Clinically Significant CMV Infections in Patients Receiving Ptcy-Based Hematopoietic Cell Transplantation

早期巨细胞病毒(CMV)病毒载量负担可预测接受Ptcy为基础的造血细胞移植患者晚期临床显著CMV感染。

BLOOD
IF23.1
2024-11-050
PRE
Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors
2023-06-011
OAAI
What causes aplastic anaemia?
LEUKEMIA
IF13.4
2023-04-276
OA
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma

三联疗法,移植和维持直到骨髓瘤进展

2022-07-14241
OA
Comparison of hematopoietic cell transplant conditioning regimens for hemophagocytic lymphohistiocytosis disorders
2022-03-0120
OAAI
Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States

美国异基因造血干细胞移植后的社区健康状况和结局

CANCER
IF5.1
2020-10-2113
OAAI
Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia

重型再生障碍性贫血骨髓移植预处理方案的选择

2019-10-2240
OA
Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: low incidence of lower gastrointestinal tract disease
2018-01-1938
OAAI